Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J N Raymakers

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
JAMA|October 6, 2025
Inhaler-Related Greenhouse Gas Emissions in the US: A Serial Cross-Sectional AnalysisWilliam B Feldman, Jihye Han, Adam J N Raymakers, et al.
JAMA Dermatology|February 21, 2024
Use of Efficiency Frontiers to Align Prices and Clinical Benefits of Biologic Therapies for Plaque PsoriasisAlexander C Egilman, Aaron S Kesselheim, Jerry Avorn, et al.
Chest|February 7, 2018
ResponseAdam J N Raymakers, Mohsen Sadatsafavi, Don D Sin, et al.
Pharmacoeconomics|January 19, 2021
Early-Phase Clinical Trials and Reimbursement Submissions to the Pan-Canadian Oncology Drug ReviewAdam J N Raymakers, Kristina M Jenei, Dean A Regier, et al.
Chest|February 17, 2017
The Impact of Statin Drug Use on All-Cause Mortality in Patients With COPD: A Population-Based Cohort StudyAdam J N Raymakers, Mohsen Sadatsafavi, Don D Sin, et al.
Journal of General Internal Medicine|September 17, 2025
Modeling the Budgetary Impacts of Sickle Cell Disease Gene Therapies on State Medicaid ProgramsJessica Preston Harvey, Adam J N Raymakers, Leah Z Rand, et al.
Respirology (Carlton, Vic.)|October 21, 2016
Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic reviewAdam J N Raymakers, Natalie McCormick, Carlo A Marra, et al.
Drug Discovery Today|May 1, 2024
How health technology assessment can help to address challenges in drug repurposing: a conceptual frameworkTeebah Abu-Zahra, Sabine E Grimm, Mirre Scholte, et al.
Applied Health Economics and Health Policy|February 14, 2016
Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic ReviewAdam J N Raymakers, John Mayo, Stephen Lam, et al.
The European Respiratory Journal|March 22, 2020
Avoiding immortal time bias in observational studiesAdam J N Raymakers, Mohsen Sadatsafavi, Don D Sin, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
JAMA|October 6, 2025
Inhaler-Related Greenhouse Gas Emissions in the US: A Serial Cross-Sectional AnalysisWilliam B Feldman, Jihye Han, Adam J N Raymakers, et al.
JAMA Dermatology|February 21, 2024
Use of Efficiency Frontiers to Align Prices and Clinical Benefits of Biologic Therapies for Plaque PsoriasisAlexander C Egilman, Aaron S Kesselheim, Jerry Avorn, et al.
Chest|February 7, 2018
ResponseAdam J N Raymakers, Mohsen Sadatsafavi, Don D Sin, et al.
Pharmacoeconomics|January 19, 2021
Early-Phase Clinical Trials and Reimbursement Submissions to the Pan-Canadian Oncology Drug ReviewAdam J N Raymakers, Kristina M Jenei, Dean A Regier, et al.
Chest|February 17, 2017
The Impact of Statin Drug Use on All-Cause Mortality in Patients With COPD: A Population-Based Cohort StudyAdam J N Raymakers, Mohsen Sadatsafavi, Don D Sin, et al.
Journal of General Internal Medicine|September 17, 2025
Modeling the Budgetary Impacts of Sickle Cell Disease Gene Therapies on State Medicaid ProgramsJessica Preston Harvey, Adam J N Raymakers, Leah Z Rand, et al.
Respirology (Carlton, Vic.)|October 21, 2016
Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic reviewAdam J N Raymakers, Natalie McCormick, Carlo A Marra, et al.
Drug Discovery Today|May 1, 2024
How health technology assessment can help to address challenges in drug repurposing: a conceptual frameworkTeebah Abu-Zahra, Sabine E Grimm, Mirre Scholte, et al.
Applied Health Economics and Health Policy|February 14, 2016
Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic ReviewAdam J N Raymakers, John Mayo, Stephen Lam, et al.
The European Respiratory Journal|March 22, 2020
Avoiding immortal time bias in observational studiesAdam J N Raymakers, Mohsen Sadatsafavi, Don D Sin, et al.
Pageof 4